Skip to main content
. 2025 Aug 23;25:880. doi: 10.1186/s12884-025-07954-w

Table 1.

General characteristics of the enrolled women

Variable Controls GH PE sPE P-value
(n = 41) (n = 45) (n = 47) (n = 73)
Age, years 28.20 ± 4.79 29.24 ± 5.52 29.81 ± 5.83 30.52 ± 6.19 0.21
BMI (kg/m2) 28.17 ± 3.84 30.40 ± 3.30 30.70 ± 4.51 31.59 ± 4.72 < 0.001
GA 38.86 ± 0.90 38.39 ± 1.78 37.56 ± 2.25 35.64 ± 3.66 < 0.001
SBP (mmHg) 117.83 ± 19.64 141.13 ± 9.97 148.68 ± 9.60 165.55 ± 17.14 < 0.001
DBP (mmHg) 81.10 ± 6.60 95.20 ± 6.69 99.00 ± 4.78 109.04 ± 15.42 < 0.001
ALP (IU/L) 124.49 ± 36.70 139.94 ± 53.53 147.43 ± 47.68 136.00 ± 45.57 0.138
LDH(IU/L) 178.43 ± 37.75 208.77 ± 53.66 228.54 ± 59.67 255.26 ± 66.36 < 0.001
ALT (IU/L) 9.46 ± 4.63 9.76 ± 5.93 9.69 ± 5.61 13.12 ± 8.00 0.004
AST (IU/L) 14.93 ± 4.48 15.62 ± 6.10 17.06 ± 7.23 20.06 ± 7.68 < 0.001
BUN (mmol/L) 3.48 ± 1.23 3.37 ± 0.90 3.84 ± 1.30 4.17 ± 2.00 0.02
SCr (umol/L) 49.42 ± 9.55 55.24 ± 12.20 60.51 ± 14.78 62.87 ± 25.80 0.002
UA (umol/L) 284.65 ± 60.78 325.37 ± 79.26 383.55 ± 108.92 397.04 ± 95.69 < 0.001
WBC (109/L) 9.13 ± 2.17 9.28 ± 1.92 8.59 ± 1.98 9.43 ± 2.20 0.187
PDW(fL) 12.93 ± 2.19 14.16 ± 2.02 15.05 ± 2.01 15.60 ± 2.01 < 0.001
MPV (fL) 10.81 ± 1.08 11.14 ± 1.27 11.49 ± 1.28 11.25 ± 1.21 0.077
PLT (109/L) 219.73 ± 50.67 219.33 ± 67.04 199.38 ± 61.77 197.30 ± 68.13 0.128
NT-proBNP (pg/mL) 20.50(12.05,28.00) 42.50(30.00,61.40) 144.60(77.80,209.50) 266.8(160.60,379.65) < 0.001
Adverse pregnancy outcomes 0 8 (17.8%) 22 (44.7%) 55 (75.3%) < 0.001

GA Gestational age, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, ALP alkaline phosphatase, LDH lactate dehydrogenase, ALT alanine aminotransferase, AST aspartate aminotransferase, BUN blood urea nitrogen Alanine, SCr serum creatinine, UA uric acid, WBC white blood cell, PLT platelet, MPV mean platelet volume, PDW platelet distribution width, NT-proBNP N-terminal pro-brain natriuretic peptide. The data were analyzed by one-way ANOVA and Kruskal–Wallis tests